Get all your news in one place.
100's of premium titles.
One app.
Start reading
The Guardian - UK
The Guardian - UK
Politics
Jamie Grierson

Weight-loss jab rejected for NHS use by England drugs watchdog

Mounjaro box
The weekly injection is used to treat adults with type 2 diabetes. Photograph: George Frey/Reuters

A weight-loss jab has been rejected for NHS use by England’s drugs watchdog.

The National Institute for Health and Care Excellence (Nice), which provides recommendations and guidance to health practitioners, said further evidence was needed on the clinical and cost-effectiveness of tirzepatide, which is sold under the brand name Mounjaro, before it could be recommended for NHS use.

Sign up to read this article
Read news from 100's of titles, curated specifically for you.
Already a member? Sign in here
Related Stories
Top stories on inkl right now
One subscription that gives you access to news from hundreds of sites
Already a member? Sign in here
Our Picks
Fourteen days free
Download the app
One app. One membership.
100+ trusted global sources.